William Miyazaki
Family Medicine · Reno, NVNPI 1609904507
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 267 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,903 and has fallen 96.0% since, to $77 in 2024. Among family medicine clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 267 payments — averaging $19.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amarin Pharma, Inc.$737
- AstraZeneca$717
- Amgen$505
- Johnson & Johnson$424
- AbbVie$301
- Lilly USA, LLC$288
- plus $2K from 19 others
What the payments were for
- Food & beverage$5,17099%
- Education$661%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amarin Pharma, Inc. | 52 | $737 |
| AstraZeneca | 26 | $717 |
| Amgen(2 entities) | 19 | $505 |
| Johnson & Johnson | 25 | $424 |
| AbbVie(2 entities) | 21 | $301 |
| Lilly USA, LLC | 12 | $288 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $243 |
| Boehringer Ingelheim | 11 | $238 |
| Kowa Pharmaceuticals America, Inc. | 12 | $223 |
| Pfizer | 9 | $214 |
| Esperion Therapeutics, Inc. | 18 | $208 |
| Sanofi-aventis U.S. LLC | 11 | $189 |
| Novo Nordisk | 3 | $150 |
| Eisai Inc. | 8 | $138 |
| GSK | 5 | $131 |
| Merck | 7 | $120 |
| Gilead | 1 | $101 |
| Abbott | 5 | $95 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $83 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $34 |
| Tactile Systems Technology Inc | 2 | $30 |
| Alfasigma USA, Inc. | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Zyla Life Sciences, Inc. | 1 | $16 |
| Bayer | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,236 in reported general payments places this provider in the 90th percentile of 902 family medicine providers in Nevada.
Other family medicine in Reno
- Bayo Curry-WinchellReno$74K
- Catherine McCarthyReno$68K
- Francisco DofelizReno$30K
- Michael ObrienReno$18K
- James McLennanReno$16K
- Jeremy BearfieldReno$15K
- Ricardo GonzalezReno$11K
- Jennifer HornbackReno$11K
- Ambika UppuReno$11K
- Vance AlmReno$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.